These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17500309)

  • 21. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
    Hirschfeld RM; Kasper S
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine].
    Leclercq V; Lacaille S; Delpierre S; Karoubi E; Legrain S
    Rev Med Interne; 2005 Oct; 26(10):835-6. PubMed ID: 16023268
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of bipolar disorders].
    Schmauss M; Messer T
    MMW Fortschr Med; 2009 Mar; 151(13):74-8. PubMed ID: 19504825
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs for bipolar disorder.
    Med Lett Drugs Ther; 2016 Aug; 58(1501):103-6. PubMed ID: 27508348
    [No Abstract]   [Full Text] [Related]  

  • 26. Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data.
    Akiskal HS; Fuller MA; Hirschfeld RM; Keck PE; Ketter TA; Weisler RH
    CNS Spectr; 2005 Jun; 10(6):suppl 1-11; discuss 12-3; quiz 14-5. PubMed ID: 16041864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practical considerations for carbamazepine use in bipolar disorder.
    Fuller MA; Dostrow V; Gupta S; Gazda TD
    Expert Opin Drug Saf; 2006 Jul; 5(4):501-9. PubMed ID: 16774489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
    Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB
    J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood stabilizers in the treatment of juvenile bipolar disorder. Advances and controversies.
    Davanzo PA; McCracken JT
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):159-82. PubMed ID: 10674195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case study: carbamazepine treatment of juvenile-onset bipolar disorder.
    Woolston JL
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):335-8. PubMed ID: 10087696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
    Muzina DJ; Elhaj O; Gajwani P; Gao K; Calabrese JR
    Acta Psychiatr Scand Suppl; 2005; (426):21-8. PubMed ID: 15833097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision model for the acute treatment of mania.
    Steffens DC; Krishnan KR
    Depress Anxiety; 1996-1997; 4(6):289-93. PubMed ID: 9166657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating bipolar disorder: monotherapy versus combination therapy.
    Ketter TA
    J Clin Psychiatry; 2009 Feb; 70(2):e42. PubMed ID: 19265641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.
    Liu HY; Potter MP; Woodworth KY; Yorks DM; Petty CR; Wozniak JR; Faraone SV; Biederman J
    J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):749-62.e39. PubMed ID: 21784295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ; Kang WH; Li Q; Tan QR
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study.
    El-Mallakh RS; Salem MR; Chopra AS; Mickus GJ; Penagaluri P
    Int Clin Psychopharmacol; 2009 May; 24(3):145-9. PubMed ID: 19367153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Woman on the verge.
    Phillips H
    Ment Health Today; 2006 Apr; ():35. PubMed ID: 16617958
    [No Abstract]   [Full Text] [Related]  

  • 40. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
    Vieta E; Cruz N; García-Campayo J; de Arce R; Manuel Crespo J; Vallès V; Pérez-Blanco J; Roca E; Manuel Olivares J; Moríñigo A; Fernández-Villamor R; Comes M
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.